Both subungual and periungual warts are caused by an infection called the human papillomavirus (HPV). There are hundreds of types of HPV. The different strains of the infection affect you differently.

Quince Therapeutics is advancing eDSP for Ataxia-Telangiectasia, leveraging strong prior data in the 6-9 age group and an innovative AIDE platform. Recent insider buying, new analyst coverage with ...

Telangiectasia refers to small, dilated blood vessels visible near the skin or mucous membranes' surface, often appearing on the face, legs, chest, or other areas. These vessels may be red, blue ...

Periungual warts develop around the finger and toenails. As they expand, they can cause discomfort or pain and may disrupt nail growth. Possible treatments include salicylic acid, cryotherapy ...

Periungual telangiectasias are characteristic of autoimmune diseases (lupus, dermatomyositis, and scleroderma). When mat-like and mucosal, CREST syndrome and hereditary hemorrhagic telangiectasia ...

SAN DIEGO — In this Healio Video Perspective from Eyecelerator@ASCRS, Jim Mazzo and Rich Small, CEO of Neurotech Pharmaceuticals, present a novel encapsulated cell therapy for long-term ...

WAILEA, Hawaii —NT-501, an encapsulated cell therapy for the treatment of macular telangiectasia type 2, met its primary endpoints across two phase 3 trials, according to a speaker at Retina 2024.

Hereditary hemorrhagic telangiectasia, previous known as Rendu–Oslar–Weber disease, is an autosomal dominant inherited disease characterized by telangiectasia of skin, mucous membrane and ...

Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel) - ENCELTO is the First and Only FDA-approved Treatment for ...

Tuberous sclerosis complex presenting as periungual fibromas and seizures in a 52-year-old woman Daniel Ortega-Quijano , Bibiana Pérez-García , Sergio Vañó-Galván CMAJ Jun 2020, 192 (26) E714; DOI: 10 ...

EryDel SpA, a global late-stage biotech company aimed at developing and commercializing therapies for the treatment of rare diseases delivered by its proprietary red blood cell technology ...

Macular Telangiectasia Type 2 (MacTel), or idiopathic macular telangiectasia type 2, is a bilateral, neurodegenerative disease in adults with characteristic localized retinal degeneration, a group ...